Do you have a sense that DE and the new Board members are excited about the future, despite the unexpected barriers that the FDA has presented? In other words, are they regarding that as a temporary hurdle to deal with, and they are already looking beyond it?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.